Results 11 to 20 of about 53,200 (233)

Chagas Disease and Heart Failure: An Expanding Issue Worldwide [PDF]

European Cardiology Review, 2019
Chagas disease, originally a South American endemic health problem, is expanding worldwide because of people migration. Its main impact is on the cardiovascular system, producing myocardial damage that frequently results in heart failure.
Felipe Martinez, Eduardo Perna, Sergio V Perrone, Alvaro Sosa Liprandi   +3 more
doaj   +2 more sources

Chagas disease. [PDF]

CMAJ
More than 300,000 people in the United States are infected with Trypanosoma cruzi, the parasite that causes Chagas disease\u2013and most don\u2019t know it.2014Health ...
Billick MJ, Silverberg SL.
europepmc   +3 more sources

Chagas Disease [PDF]

, 2021
Despite being described for the first time more than 110 years ago, Chagas disease (caused by the parasite Trypanosoma cruzi) persists as one of the most neglected tropical diseases.

core   +1 more source

Molecular epidemiologic source tracking of orally transmitted Chagas disease, Venezuela. [PDF]

, 2013
Oral outbreaks of Chagas disease are increasingly reported in Latin America. The transitory presence of Trypanosoma cruzi parasites within contaminated foods, and the rapid consumption of those foods, precludes precise identification of outbreak origin ...
Hernán J. Carrasco, Juan C. Londoño, Cinda Martínez, Michael A. Miles, Rafael Bonfante-Cabarcas, Carrasco, Hernán J, Bonfante-Cabarcas, Rafael, de Noya, Belkisyolé A, Louisa A. Messenger, Londoño, Juan C, Raul Espinosa, Martínez, Clara E, Martínez, Cinda, Anaibeth Nessi, Nessi, Anaibeth, Mijares Alfredo, Messenger, Louisa A, Alfredo, Mijares, Martin S. Llewellyn, Michael D. Lewis, Llewellyn, Martin S, Segovia, Maikell, Miles, Michael A, Espinosa, Raul, Lewis, Michael D, Clara E. Martínez, Maikell Segovia, Belkisyolé A. de Noya   +27 more
core   +1 more source

Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis. [PDF]

, 2015
BACKGROUND: Few studies have assessed the burden of Chagas disease in non-endemic countries and most of them are based on prevalence estimates from Latin American (LA) countries that likely differ from the prevalence in migrants living in Europe. The aim
Muñoz Jose, Elisa Sicuri, Muñoz, J, Sicuri, Elisa, de Lazzari Elisa, Joaquim Gascon, Ana Requena-Méndez (101960), Joaquim Gascón (91277), Moore, David AJ, Moore, David A. J., de Lazzari, Elisa, Elisa de Lazzari, de Lazzari, E, Michael Brown, Brown, Michael, Lazzari, Elisa de, Moore David A. J., Requena-Méndez, A, Jose Muñoz, Sicuri, E, David A. J. Moore (81163), Muñoz, Jose, Ana Requena-Méndez, Gascon Joaquim, Gascón i Brustenga, Joaquim, Moore, DA, David A J Moore, Aldasoro, Edelweiss, José Muñoz (91279), Requena-Méndez Ana, Aldasoro Edelweiss, Requena-Méndez, Ana, Sicuri Elisa, Gascon, Joaquim, Michael Brown (219384), Brown Michael, Edelweiss Aldasoro, Edelweiss Aldasoro (288004), Gascon, J, Elisa De Lazzari (672963), Aldasoro, E, Elisa Sicuri (247271), Brown, M   +42 more
core   +1 more source

Key Chagas disease missing knowledge among at-risk population in Spain affecting diagnosis and treatment

Infectious Diseases of Poverty, 2021
Background Chagas disease is endemic in Latin America and, over the last few decades, due to population movements, the disease has spread to other continents. Early diagnosis and treatment are critical in terms of improving outcomes for those living with
María Romay-Barja, Laura Iglesias-Rus, Teresa Boquete, Agustín Benito, Teresa Blasco-Hernández   +4 more
doaj   +1 more source

Systemic antibiotics for preventing ventilator-associated pneumonia in comatose patients: a systematic review and meta-analysis

Annals of Intensive Care, 2017
Background Early-onset ventilator-associated pneumonia (EO-VAP) is the leading cause of morbidity and mortality in comatose patients. However, VAP prevention bundles focus mainly on late-onset VAP and may be less effective in preventing EO-VAP in ...
Cássia Righy, Pedro Emmanuel Americano do Brasil, Jordi Vallés, Fernando A. Bozza, Ignacio Martin-Loeches   +4 more
doaj   +1 more source

Insights from quantitative and mathematical modelling on the proposed WHO 2030 goals for Chagas disease [version 1; peer review: 2 approved]

Gates Open Research, 2019
Chagas disease (CD) persists as one of the neglected tropical diseases (NTDs) with a particularly large impact in the Americas. The World Health Organization (WHO) recently proposed goals for CD elimination as a public health problem to be reached by ...
Collaborating Group on Chagas Disease Modelling
doaj   +1 more source

Current knowledge of Chagas-related heart disease among pediatric cardiologists in the United States

BMC Cardiovascular Disorders, 2021
Background Chagas disease is a pathogenic parasitic infection with approximately 8 million cases worldwide and greater than 300,000 cases in the United States (U.S.).
Sanchi Malhotra, Imran Masood, Noberto Giglio, Jay D. Pruetz, Pia S. Pannaraj   +4 more
doaj   +1 more source

A multicenter comparative study of the performance of four rapid immunochromatographic tests for the detection of anti-Trypanosoma cruzi antibodies in Brazil

Frontiers in Medicine, 2023
Diagnosis of Trypanosoma cruzi (T. cruzi) infection in the chronic phase of Chagas disease (CD) is performed by serologic testing. Conventional tests are currently used with very good results but require time, laboratory infrastructure, and expertise ...
Jacqueline Araújo Domingos Iturra, Leonardo Maia Leony, Fernanda Alvarenga Cardoso Medeiros, Job Alves de Souza Filho, Liliane da Rocha Siriano, Suelene Brito Tavares, Alejandro Ostermayer Luquetti, Vinícius Silva Belo, Andréa Silvestre de Sousa, Andréa Silvestre de Sousa, Fred Luciano Neves Santos, Fred Luciano Neves Santos   +11 more
doaj   +1 more source